Skip to main content
I

IMAGION BIOSYSTEMS LIMITED — Investor Relations & Filings

Ticker · IBX ISIN · AU000000IBX6 ASX Professional, scientific and technical activities
Open in API
Filings indexed 653 across all filing types
Latest filing 2026-04-23 Proxy Solicitation & In…
Country AU Australia
Listing ASX IBX

About IMAGION BIOSYSTEMS LIMITED

https://imagionbiosystems.com/

Imagion Biosystems Limited is a medical technology company specializing in the development of advanced diagnostic imaging solutions. The company's proprietary MagSense technology utilizes superparamagnetic iron oxide nanoparticles to detect specific cancer cells non-invasively. By functionalizing these nanoparticles with targeting antibodies, the system can identify the presence and location of malignancies, such as HER2-positive breast cancer, using highly sensitive magnetic sensors. This approach aims to provide a safer, more accurate alternative to traditional biopsy and imaging methods by eliminating the need for ionizing radiation or radioactive tracers. The technology is designed to improve clinical decision-making through earlier detection and better staging of diseases, ultimately enhancing patient outcomes in oncology.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting/Proxy Form 32 pages 953.7KB
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the formal Notice of Annual General Meeting (AGM) together with the Explanatory Statement and Proxy Form, sent to shareholders to provide information on proposed resolutions and to solicit their votes prior to the virtual meeting. It does not present actual AGM presentations or slides, nor is it the full annual report or earnings release. It corresponds to the category for materials sent to shareholders to request votes and provide meeting information (Proxy Solicitation & Information Statement).
2026-04-23 English
Appendix 4C and Quarterly Activities Report - March 2026 8 pages 810.8KB
Interim / Quarterly Report Classification · 1% confidence The document is an 'Appendix 4C' quarterly cash flow report combined with a 'Quarterly Activities Report' for Imagion Biosystems. Under ASX listing rules, this is a standard quarterly financial disclosure. Since it contains substantive financial statements (the cash flow statement) and management analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). Q1 2026
2026-04-22 English
Cleansing Statement - Section 708A(12C)(e) 10 pages 522.1KB
Capital/Financing Update Classification · 1% confidence The document is a detailed ASX “Company Announcement” providing a Cleansing Notice under section 708A of the Corporations Act relating to the issue of convertible notes, including material terms, pro forma impact on the capital structure, and rights attaching to shares on conversion. It is not a full financial report (10-K/IR), not an earnings release or call transcript, nor a board change notice. It clearly describes a financing activity (issuance of convertible notes), fitting the definition of a Capital/Financing Update (CAP).
2026-04-22 English
Notification regarding unquoted securities - IBX 9 pages 25.3KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3G filing titled “Notification of issue, conversion or payment up of unquoted equity securities,” detailing the issuance of convertible notes and options, quantities, dates, and terms. This is an announcement of new security issuances (capital changes). It fits the “Share Issue/Capital Change” category, not an annual report or other report type.
2026-04-22 English
Proposed issue of securities - IBX 6 pages 23.0KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3B outlining the proposed issue of securities (placement of convertible notes and options) by Imagion Biosystems. It provides detailed terms of the share issue, including number of securities, issue price, conditions, and listing rule compliance. This falls squarely under Share Issue/Capital Change.
2026-04-15 English
IBX Update Regarding Short Term Funding Facilities 2 pages 386.7KB
Regulatory Filings
2026-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.